ARTV vs NVST · $37.3M cap vs P/E 56, rev $1.44B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
ARTV currently screens at market cap $37.3M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the ARTV and NVST stock pages for the full models.
Not investment advice.